Endotoxin removal relies on the physicochemical differences between proteins and lipopolysaccharides (LPS). Key methods include Triton X-114 phase separation, anion-exchange chromatography (AEX), and polymyxin B affinity chromatography. The choice of method depends on the target protein’s size, charge, isoelectric point, hydrophobicity, stability, and intended application. Triton X-114 can provide strong endotoxin reduction for many soluble, detergent-tolerant proteins. Anion-exchange chromatography offers a scalable, detergent-free option when buffer pH and conductivity are carefully optimized. Affinity-based media can provide selective LPS capture during final polishing. Reliable recombinant protein purification should combine endotoxin reduction with protein-recovery measurements, functional testing, and a validated bacterial endotoxin assay.
What Is Endotoxin?
Endotoxin is a form of lipopolysaccharide found in the outer membrane of Gram-negative bacteria, including Escherichia coli. Because E. coli is widely used for recombinant protein expression, proteins produced in this host frequently require dedicated endotoxin control. LPS contains three main structural regions: lipid A, a core oligosaccharide, and the O-antigen. Lipid A is primarily responsible for the strong biological activity associated with endotoxin. Its hydrophobic character, combined with negatively charged phosphate groups elsewhere in the molecule, gives LPS complex physicochemical properties.
This combination of charge and hydrophobicity is also useful during purification. Anion-exchange chromatography can capture negatively charged LPS, while Triton X-114 can separate endotoxin through its hydrophobic lipid region.
Why Recombinant Proteins Become Contaminated
During bacterial expression, endotoxin remains associated with the outer cell membrane. Cell harvesting, disruption, sonication, homogenization, and chemical lysis release LPS into the lysate, where it can associate with the target protein.
Endotoxin contamination may also enter the process through water, buffers, chromatography equipment, storage containers, or reused laboratory supplies. A successfully purified protein can therefore become contaminated again if final handling is not performed with appropriate endotoxin-controlled materials. Proteins recovered from soluble bacterial fractions and inclusion bodies may carry different endotoxin loads. In the original Liu et al. comparison, some proteins expressed in the soluble fraction contained more endotoxin than proteins recovered from inclusion bodies. The result highlights how expression format and recovery conditions can influence the starting contamination level.
Why Endotoxin Removal Is Important
Even a highly pure recombinant protein may produce misleading results if residual LPS is present. Endotoxin can activate innate immune pathways, stimulate cytokine production, and alter cellular responses. This is especially important in experiments involving macrophages, monocytes, dendritic cells, and other immune-responsive systems. Endotoxin contamination has historically complicated the interpretation of biological activity attributed to bacterially expressed recombinant proteins. A protein may appear to stimulate an inflammatory pathway when contaminating LPS partly or primarily causes the response.
Endotoxin control is particularly important for:
- Immune-cell experiments
- Cytokine and inflammation studies
- Animal immunization
- Vaccine research
- Injectable proteins
- Biopharmaceutical development
The required final endotoxin level should be determined by the intended use, administered dose, route of exposure, and applicable quality requirements rather than by applying one universal value to every protein preparation.
Why Is Endotoxin Removal from Proteins Challenging?
LPS does not behave as a single, consistently sized molecule in aqueous solution. It can form micelles, vesicles, and larger aggregates. It can also bind directly to proteins through hydrophobic, electrostatic, or mixed interactions. As a result, endotoxin may exist as free LPS, aggregated LPS, or protein-bound LPS. These forms can behave differently during chromatography and filtration.
A size-based membrane may remove one LPS population while retaining another. An anion-exchange resin may capture free negatively charged LPS but perform differently when endotoxin is strongly associated with the target protein. Hydrophobic extraction may remove LPS efficiently but may also affect a hydrophobic or detergent-sensitive protein.
A widely cited review concluded that no general endotoxin removal method is effective for every protein solution. Method development must account for both the properties of LPS and the individual characteristics of the target protein.

Best Methods for Endotoxin Removal in Protein Purification
The best methods for endotoxin removal in protein purification are those that achieve the required LPS reduction while maintaining protein recovery, purity, structure, and biological activity. For many projects, the strongest strategy is not a single treatment but a carefully designed combination of capture, depletion, polishing, and final testing.
Triton X-114 Phase Separation for Endotoxin Removal
Triton X-114 phase separation is one of the most established methods for endotoxin removal from proteins. Triton X-114 is a nonionic detergent that forms a uniform solution under cold conditions. When the sample is warmed above its cloud-point temperature, it separates into an aqueous phase and a detergent-rich phase. The hydrophobic lipid A portion of LPS preferentially enters the detergent-rich phase. Many soluble hydrophilic proteins remain in the aqueous phase and can be recovered after centrifugation.
In the Liu et al. study, Triton X-114 was compared with immobilized polymyxin B and immobilized histidine. Three cycles of phase separation reduced endotoxin by more than 99%, while protein recovery remained above 90% for the tested preparations. Most proteins retained their immunoreactivity, and cardiac troponin I maintained its ability to bind troponin C. These findings make Triton X-114 an attractive option for soluble proteins that tolerate detergent exposure and controlled temperature changes. However, the result should not be interpreted as proof that Triton X-114 is universally superior.
Hydrophobic proteins, membrane-associated proteins, and some protein complexes may partition into the detergent-rich phase. Repeated extraction can also increase processing time and cumulative protein loss. Residual Triton X-114 should be removed through a suitable polishing or buffer-exchange step and evaluated when it could affect downstream experiments.
A later integrated approach incorporated a Triton X-114 wash directly into several common chromatography workflows. The method produced substantial endotoxin reduction during Ni-NTA, MBP, GST, Protein A, cation-exchange, and other compatible purification procedures, demonstrating that detergent-based depletion can sometimes be integrated rather than performed as a completely separate process.
Anion-Exchange Chromatography
Anion-exchange chromatography, or AEX, uses a positively charged stationary phase to capture negatively charged molecules. Because LPS contains negatively charged phosphate groups, it can bind strongly to anion-exchange media under suitable conditions. A common strategy is to design a flow-through method in which endotoxin binds to the resin while the target protein passes through the column. This can be effective, scalable, and compatible with standard recombinant protein purification systems.
The most important variables are buffer pH, conductivity, salt concentration, resin chemistry, protein concentration, and the protein’s isoelectric point. At a pH above its pI, a protein generally carries a net negative charge and may bind to the same anion-exchange resin as LPS. At a pH below its pI, the protein may carry a net positive charge and move through the column more readily. However, the selected pH must still support protein stability and solubility.
Lower conductivity generally strengthens ionic binding of LPS, while high salt can weaken endotoxin capture. Research specifically evaluating AEX for therapeutic proteins confirmed that pH, ionic strength, and sample properties materially influence selective endotoxin removal. Modern anion-exchange membrane adsorbers provide an additional option. These devices support convective flow, rapid processing, relatively low backpressure, and disposable operation. Recent work has evaluated commercial AEX membranes for reducing endotoxin risk in buffers used during ultrafiltration and diafiltration operations.
Polymyxin B and Histidine Affinity Chromatography
Polymyxin B binds to the lipid A region of endotoxin. When immobilized on a chromatography matrix, it can selectively capture LPS while allowing the target protein to remain in the flow-through. Polymyxin B affinity media can be convenient for small and medium laboratory preparations or as a final polishing step. Its effectiveness depends on the starting endotoxin load, resin capacity, LPS source, buffer composition, and strength of protein–LPS association.
Potential limitations include nonspecific protein adsorption, incomplete removal of protein-bound endotoxin, limited binding capacity, and possible ligand leaching. These factors should be evaluated during method qualification. Immobilized histidine has also been used because endotoxin can interact with histidine-rich and positively charged surfaces. Liu et al. included histidine affinity chromatography in their comparison, although it was less effective than Triton X-114 under the conditions tested.
Adding soluble polymyxin B to a biological assay may neutralize part of the LPS response, but neutralization is not equivalent to physically removing endotoxin from the protein preparation. The final sample should still be tested directly.
Ultrafiltration, SEC, and Membrane-Based Polishing
Ultrafiltration and diafiltration are useful for concentrating proteins, adjusting conductivity, exchanging buffers, and removing small process reagents. They are less reliable as standalone endotoxin removal methods because LPS can form aggregates larger than the membrane cutoff or remain bound to the retained protein. Size exclusion chromatography can support final buffer exchange, aggregate analysis, and removal of residual detergent. However, it is not usually the strongest primary method for endotoxin removal from proteins. LPS aggregates have variable hydrodynamic sizes and may co-elute with the target protein.
SEC and UF/DF are therefore most valuable as supporting operations in a combined purification process.

Comparison of Endotoxin Removal Methods
|
Method |
Best suited for |
Main advantage |
Main consideration |
|
Triton X-114 |
Soluble, detergent-tolerant proteins |
Strong LPS partitioning |
Residual detergent and protein compatibility |
|
Anion exchange |
Scalable purification and polishing |
Detergent-free and process-friendly |
Protein charge, pH, and conductivity |
|
Polymyxin B affinity |
Selective laboratory-scale polishing |
Direct lipid A binding |
Capacity and nonspecific protein loss |
|
Histidine affinity |
Compatible protein samples |
Straightforward affinity approach |
Variable selectivity |
|
UF/DF |
Concentration and buffer exchange |
Scalable supporting step |
Protein-bound LPS may be retained |
|
Size exclusion |
Final polishing and detergent removal |
Gentle separation |
LPS may overlap with the protein |
|
AEX membrane |
Fast flow-through processing |
High throughput and low pressure |
Requires validated loading conditions |
No method should be selected from this table alone. Small-scale testing is the most reliable way to compare endotoxin reduction, protein recovery, aggregation, and activity for a specific recombinant protein.
How to Choose the Right Endotoxin Removal Method
Protein Charge and Isoelectric Point
Protein charge is particularly important for anion-exchange chromatography. The operating pH should produce strong LPS binding while minimizing unwanted target-protein retention. A protein with a high pI may remain positively charged at neutral pH and pass through an AEX column efficiently. An acidic protein may bind to the resin alongside LPS, requiring a different pH, another chromatographic mode, or an alternative depletion method.
Protein Hydrophobicity and Stability
Triton X-114 is often suitable for soluble hydrophilic proteins, but hydrophobic proteins may enter the detergent-rich phase. Detergent-sensitive complexes may also dissociate or change conformation.
Method development should evaluate:
- Detergent tolerance
- Temperature stability
- pH stability
- Low-salt stability
- Aggregation tendency
- Cofactor requirements
- Oligomeric state
A successful method should protect the biological value of the protein rather than focusing only on the lowest endotoxin number.
Starting Load, Scale, and Application
A highly contaminated bacterial lysate may require an early depletion step followed by chromatographic polishing. A relatively clean purified sample may need only a selective affinity column or AEX membrane. Processing scale also matters. Triton X-114 can be convenient at laboratory scale, while packed-bed AEX, membrane adsorbers, and integrated flow-through operations may offer practical advantages during scale-up.
For immune-cell assays, even a small amount of residual LPS may alter the result. For regulated injectable products, endotoxin specifications and testing must follow product-specific and compendial requirements. FDA’s March 2026 guidance discusses gel-clot, photometric, and kinetic bacterial endotoxin test methods and emphasizes appropriate testing of components and finished products.

A Practical Recombinant Protein Purification Workflow
Prevent Contamination Early
The most efficient endotoxin removal strategy begins with prevention. Use endotoxin-controlled water, freshly prepared buffers, suitable plasticware, clean chromatography equipment, and properly prepared collection containers. Processing bacterial lysates promptly can reduce opportunities for continued LPS release and protein–endotoxin association. Keeping high-endotoxin fractions separate from final polishing equipment also supports consistent results.
Engineered E. coli strains with modified lipid A biosynthesis provide another preventive approach. Such hosts can produce recombinant proteins with reduced activation of human TLR4 pathways, although suitability should be confirmed for the intended assay and biological species.
Optimize at Small Scale
Before processing the complete sample, test several conditions using a small portion of the protein preparation.
Compare relevant combinations of:
- Buffer pH
- Conductivity
- Salt concentration
- Detergent concentration
- Resin load
- Contact time
- Number of extraction cycles
For each condition, measure final endotoxin, protein recovery, purity, aggregation, and biological activity. The condition with the lowest endotoxin is not necessarily the best if protein recovery or function is substantially reduced.
Use a Combined Process When Needed
A robust workflow may include:
- Affinity or ion-exchange capture
- Triton X-114 extraction or on-column depletion
- AEX flow-through polishing
- UF/DF or SEC for detergent removal and buffer exchange
- Final endotoxin and protein-quality testing
Combined workflows are especially useful when LPS exists in more than one physical form or interacts strongly with the target protein.
Endotoxin Testing After Purification
LAL and Recombinant Assays
The Limulus amebocyte lysate assay remains a widely used method for bacterial endotoxin testing. Available formats include gel-clot, chromogenic, and turbidimetric assays, with endpoint and kinetic options. The Liu et al. study used a LAL gel-clot assay. Modern quantitative formats can provide more detailed information during process development.
Recombinant Factor C and recombinant cascade-based tests are additional options. FDA’s current position is that recombinant reagents may be used when the analytical method is demonstrated to be suitable for its intended purpose.
Endotoxin Masking and Assay Interference
A low assay result does not automatically confirm complete endotoxin removal. Proteins, detergents, salts, chelators, and formulation excipients may inhibit or enhance assay performance. Low endotoxin recovery can occur when LPS becomes masked by detergents and chelating agents. Research has shown that masked LPS may produce little response in Factor C-based assays while remaining biologically active in TLR4 reporter cells and primary human monocytes.
Assay validation should therefore include a positive product control, appropriate endotoxin spike recovery, multiple sample dilutions, and determination of a suitable maximum valid dilution.
Confirm Protein Recovery and Function
Endotoxin reduction should always be evaluated alongside protein quality.
Protein recovery can be calculated as:
Protein recovery (%) = protein after treatment ÷ protein before treatment × 100
Additional evaluation may include:
- SDS-PAGE or HPLC purity
- Analytical SEC for aggregation
- Enzyme activity
- Receptor or ligand binding
- Immunoreactivity
- Cell-based function
- Residual detergent testing
Emerging affinity materials aim to improve this balance. For example, anti-lipid A antibody-conjugated microparticles have been studied as a more selective approach that can improve protein recovery while maintaining endotoxin capture.
Common Endotoxin Removal Problems
Endotoxin Remains High
Persistent endotoxin may result from protein-bound LPS, excessive starting contamination, resin overloading, unsuitable conductivity, insufficient extraction cycles, or recontamination after treatment. The next step should be to determine whether the problem is method performance or assay interference. Testing several dilutions and a positive product control can reveal inhibition or masking.
Protein Recovery Is Low
Low recovery may occur when the protein binds to the endotoxin-removal resin, enters the Triton X-114 detergent phase, precipitates at the selected pH, or adsorbs to filters and tubes. Recovery can often be improved by adjusting pH, salt concentration, contact time, detergent level, protein concentration, or surface materials.
Results Vary Between Batches
Batch variability may reflect differences in cell growth, lysis efficiency, starting endotoxin load, resin condition, buffer conductivity, sample storage, or assay performance. Using defined process parameters and documenting endotoxin as both EU/mL and EU/mg protein makes comparisons more meaningful.
FAQs
What is the best method for endotoxin removal from recombinant proteins?
There is no universal best method. Triton X-114 is effective for many soluble, detergent-tolerant proteins, while anion-exchange chromatography is often preferred for scalable, detergent-free processing. Protein properties and final application should guide the choice.
How does Triton X-114 remove endotoxin?
Triton X-114 forms a detergent-rich phase above its cloud-point temperature. The hydrophobic lipid A region of endotoxin preferentially enters this phase, while many soluble proteins remain in the aqueous phase.
Can anion-exchange chromatography remove endotoxin?
Yes. Negatively charged LPS can bind to positively charged anion-exchange media. Effective removal depends on protein pI, operating pH, salt concentration, conductivity, and resin capacity.
Can size exclusion chromatography remove endotoxin?
SEC may reduce some endotoxin populations, but it is not usually reliable as a standalone method because LPS forms variable-size aggregates and can bind to proteins. SEC is more useful for final polishing, detergent removal, and buffer exchange.
How should successful endotoxin removal be confirmed?
Measure final endotoxin using a suitable validated assay and confirm protein recovery, purity, aggregation state, biological activity, and any relevant process residues.
Conclusion
Removal of endotoxin from recombinant protein preparations is an essential part of producing reliable research and biopharmaceutical materials. Triton X-114 phase separation, anion-exchange chromatography, polymyxin B affinity media, membrane adsorbers, and combined purification workflows can all provide effective endotoxin reduction when matched to the target protein. The strongest process considers the protein’s pI, charge, hydrophobicity, stability, concentration, initial endotoxin level, and intended use. It also combines careful prevention, small-scale optimization, final polishing, validated endotoxin testing, and functional protein analysis.
By treating endotoxin removal as an integrated part of recombinant protein purification rather than an isolated cleanup step, laboratories can achieve low-endotoxin preparations while protecting protein yield, native structure, and biological performance. Astor Scientific supports recombinant protein and laboratory workflows with research supplies designed to promote consistent purification, handling, and experimental results.